CDH2 and cancer: The level of endothelial protein (e.g., CCN1) is increased by the stiffening of the tumor ECM, which subsequently contributes to up-regulation of N-cadherin on the surface of the endothelium, and promotes binding between cancer cells and endothelial cells, which is an important process leading to cancer cell intravasation12.